Gene · 994
Papers2,079
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,079
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA damage checkpoint execution and the rules of its disengagement. | Front Cell Dev Biol | 2022 | 36274841 | PubTator, text mining | PubMed |
| SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive ATR Inhibitor Resistance. | Cancer Res | 2022 | 36273494 | PubTator, text mining | PubMed |
| Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2. | Cancer Res | 2022 | 36273492 | PubTator, text mining | PubMed |
| Molecular mechanism of acetylsalicylic acid in improving learning and memory impairment in APP/PS1 transgenic mice by inhibiting the abnormal cell cycle re-entry of neurons. | Front Mol Neurosci | 2022 | 36263378 | PubTator, text mining | PubMed |
| CDK12 orchestrates super-enhancer-associated CCDC137 transcription to direct hepatic metastasis in colorectal cancer. | Clin Transl Med | 2022 | 36254394 | PubTator, text mining | PubMed |
| LncRNA-PAX8-AS1 Silencing Decreases Cell Viability, Enhances Apoptosis, and Suppresses Doxorubicin Resistance in Myeloid Leukemia via the miR-378g/ERBB2 Axis. | Evid Based Complement Alternat Med | 2022 | 36248434 | PubTator, text mining | PubMed |
| Two Important Anticancer Mechanisms of Natural and Synthetic Chalcones. | Int J Mol Sci | 2022 | 36232899 | PubTator, text mining | PubMed |
| Spatial Profiling of the Prostate Cancer Tumor Microenvironment Reveals Multiple Differences in Gene Expression and Correlation with Recurrence Risk. | Cancers (Basel) | 2022 | 36230846 | PubTator, text mining | PubMed |
| Cytotoxic Mechanism of Momilactones A and B against Acute Promyelocytic Leukemia and Multiple Myeloma Cell Lines. | Cancers (Basel) | 2022 | 36230771 | PubTator, text mining | PubMed |
| A Review and In Silico Analysis of Tissue and Exosomal Circular RNAs: Opportunities and Challenges in Thyroid Cancer. | Cancers (Basel) | 2022 | 36230649 | PubTator, text mining | PubMed |
| Flying under the radar: CDH2 (N-cadherin), an important hub molecule in neurodevelopmental and neurodegenerative diseases. | Front Neurosci | 2022 | 36213737 | PubTator, text mining | PubMed |
| Network Pharmacology and Molecular Docking to Explore the Mechanism of Kangxian Decoction for Epilepsy. | Evid Based Complement Alternat Med | 2022 | 36193133 | PubTator, text mining | PubMed |
| Structural insights into the functional roles of 14-3-3 proteins. | Front Mol Biosci | 2022 | 36188227 | PubTator, text mining | PubMed |
| Peptide-based PROTAC degrader of FOXM1 suppresses cancer and decreases GLUT1 and PD-L1 expression. | J Exp Clin Cancer Res | 2022 | 36171633 | PubTator, text mining | PubMed |
| Anticancer Activity, Mechanism, and Delivery of Allyl Isothiocyanate. | Bioengineering (Basel) | 2022 | 36135016 | PubTator, text mining | PubMed |
| USP39 facilitates breast cancer cell proliferation through stabilization of FOXM1. | Am J Cancer Res | 2022 | 36119839 | PubTator, text mining | PubMed |
| Cytomegalovirus microRNAs level determination in kidney recipients post transplantation. | Virol J | 2022 | 36096838 | PubTator, text mining | PubMed |
| Construction of miRNA-mRNA network and a nomogram model of prognostic analysis for prostate cancer. | Transl Cancer Res | 2022 | 36093560 | PubTator, text mining | PubMed |
| PTPN2 in the Immunity and Tumor Immunotherapy: A Concise Review. | Int J Mol Sci | 2022 | 36077422 | PubTator, text mining | PubMed |
| Diallyl Disulfide: A Bioactive Garlic Compound with Anticancer Potential. | Front Pharmacol | 2022 | 36071845 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/994/papers?page=13